![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Consecutive versus concomitant follicle-stimulating hormone and highly purified human menopausal gonadotropin: A milder response but better quality |
Hassan Ali Maghraby, Abdel Fattah Mohamed Agameya, Manal Shafik Swelam, Nermeen Ahmed El Dabah, Ola Youssef Ahmed |
Clin Exp Reprod Med. 2022;49(2):135-141. Published online May 30, 2022 DOI: https://doi.org/10.5653/cerm.2021.05155 |
Consecutive versus concomitant follicle-stimulating hormone and highly purified human menopausal gonadotropin: A milder response but better quality Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden Gene expression profiles of cumulus cells obtained from women treated with recombinant human luteinizing hormone + recombinant human follicle-stimulating hormone or highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone alone A comparison of the efficacy and safety of combined highly purified human menopausal gonadotropin (HP-hMG) and highly purified urinary follicle stimulating hormone (HP-uFSH) versus HP-hMG alone for ovarian stimulation Characteristics of Consecutive In Vitro Fertilization Cycles Among Patients Treated with Follicle-Stimulating Hormone (FSH) and Human Menopausal Gonadotropin Versus FSH Alone Highly purified human menopausal gonadotropin (hMG-HP; Menopur®) versus purified urinary follicle stimulating hormone (Po-FSH; Ovitrop®) for the induction of superovulation in women undergoing assisted reproductive techniques Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization–intracytoplasmic sperm injection patients A differential cytokine expression profile is induced by highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone in a pre- and postovulatory mouse follicle culture model Follicular recruitment is reduced in minimal stimulation for controlled ovarian hyperstimulation using purified human menopausal gonadotropin compared to follicle stimulating hormone Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients |